Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 17, 2011
Genentech Executive Vice President Richard Scheller describes the hard financial realities of producing cutting-edge drugs for the developed world. Scheller states that it takes 15 years, on average, for a drug product to move from concept to sale. This fact, along with the company's large-scale financial investments, places tremendous pricing pressure on the finished product.